John Paulson joins Valeant’s board after his firm took a nearly $2 billion hit on Valeant

John Paulson, one of the widest known names in the hedge fund world, will be joining the board of Valeant Pharmaceuticals, the drug company announced Monday morning. Paulson became a director of the board on June 14, Valeant said. “We are pleased to welcome John...

Americans are really optimistic about the economy, but it’s no longer helping Trump: CNBC survey

Economic optimism in the United States is surging, according to the latest CNBC All-America Economic Survey, with several key components hitting all-time highs, but it’s not helping the president. The CNBC survey of 800 Americans across the country finds that 30...